Table of Contents
Journal of Allergy
Volume 2009, Article ID 804910, 5 pages
http://dx.doi.org/10.1155/2009/804910
Case Report

Cardiac Manifestations from Non-FIP1L1-PDGFR 𝛼 -Associated Hypereosinophilic Syndrome in a 13-Year-Old African American Boy

1Department of Medicine, Aurora Health Care, Milwaukee, WI 53213, USA
2Department of Pediatrics, Children's Hospital of Wisconsin, Milwaukee, WI, USA
3Department of Pediatrics, Allergy, Asthma, and Clinical Immunology, Children's Hospital of Wisconsin, Milwaukee, WI, USA
4Department of Pediatrics, Cardiology, Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, WI, USA

Received 12 March 2009; Revised 2 September 2009; Accepted 8 October 2009

Academic Editor: Garry Walsh

Copyright © 2009 Cindy M. Salm et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Chusid, D. C. Dale, B. C. West, and S. M. Wolff, “The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature,” Medicine, vol. 54, no. 1, pp. 1–27, 1975. View at Google Scholar · View at Scopus
  2. F. Roufosse, E. Cogan, and M. Goldman, “Recent advances in pathogenesis and management of hypereosinophilic syndromes,” Allergy, vol. 59, no. 7, pp. 673–689, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. Sheikh and P. F. Weller, “Clinical overview of hypereosinophilic syndromes,” Immunology and Allergy Clinics of North America, vol. 27, no. 3, pp. 333–355, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. J. F. Spry, “The hypereosinophilic syndrome: clinical features, laboratory findings and treatment,” Allergy, vol. 37, no. 8, pp. 539–551, 1982. View at Google Scholar · View at Scopus
  5. P. F. Weller and G. J. Bubley, “The idiopathic hypereosinophilic syndrome,” Blood, vol. 83, no. 10, pp. 2759–2779, 1994. View at Google Scholar · View at Scopus
  6. J. Cools, D. J. DeAngelo, J. Gotlib et al., “A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome,” The New England Journal of Medicine, vol. 348, no. 13, pp. 1201–1214, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. E. Rothenberg, A. D. Klion, F. E. Roufosse et al., “Treatment of patients with the hypereosinophilic syndrome with mepolizumab,” The New England Journal of Medicine, vol. 358, no. 12, pp. 1215–1228, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. D. Klion, J. Robyn, C. Akin et al., “Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome,” Blood, vol. 103, no. 2, pp. 473–478, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. E. Lipshultz, L. A. Sleeper, J. A. Towbin et al., “The incidence of pediatric cardiomyopathy in two regions of the United States,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1647–1655, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. L. Schwartz and S. D. Colan, “Familial restrictive cardiomyopathy with skeletal abnormalities,” American Journal of Cardiology, vol. 92, no. 5, pp. 636–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Barkhausen, P. Hunold, H. Eggebrecht et al., “Detection and characterization of intracardiac thrombi on MR imaging,” American Journal of Roentgenology, vol. 179, no. 6, pp. 1539–1544, 2002. View at Google Scholar · View at Scopus
  12. G. A. Krombach, M. Saeed, and C. B. Higgins, “Myocardial and pericardial diseases,” in Cardiovascular MRI and MRA, C. B. Higgins and A. De Roos, Eds., pp. 103–121, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2003. View at Google Scholar